Announcements Trials

Browse Landscape

Phase

Status

Completed 14 Unknown 6 Recruiting 2 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 10 Gastrointestinal 9 Thoracic 8 Breast 6 Lymphoid 3 Head & Neck 3 Sarcoma 2 Other hematologic neoplasm 2 CNS 2 Tumor-Agnostic 1 Other 1 Dermatologic 1

Conditions

Polycystic Ovary Syndrome 1 Obesity 1

Interventions

tegaserod 3 naloxegol 3 Radiotherapy 3 Cisplatin 3 Surveys and Questionnaires 2 Radiation 2 Lidocaine 2 prucalopride 1 pegfilgrastim 1 oxycodone naloxone combination 1 indole-3-carbinol 1 hydrated silica gel-based toothpaste 1 glucarpidase 1 angiotensin I (1-7) 1 alvimopan 1 aluminum hydroxide, magnesium hydroxide, drug combination 1 Vitamin D 1 Transcutaneous Electric Nerve Stimulation 1 Thyrotropin-Releasing Hormone 1 Surgical Procedures, Operative 1 Sennosides 1 Selenomethionine 1 Phenolphthalein 1 Observation 1 Nutrition Assessment 1 Neck Dissection 1 Methotrexate 1 Methods 1 Metformin 1 Magnesium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Metformin × Other × Clear all

NCT02521753 2025-04-01

OMgObPCOS

Coordinación de Investigación en Salud, Mexico

Phase NA Terminated

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡